What is ZRCN's health score?

ZRCN Inc. (ZRCN) has a TradeApes health score of 34 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is ZRCN's estimated fair value?

Based on our 5-year discounted cash flow model, ZRCN Inc.'s estimated fair value is $3.8 per share, representing a -45.7% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is ZRCN undervalued or overvalued?

Our model currently rates ZRCN as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for ZRCN... Refresh in a moment for the full analysis.

ZRCN Inc. (ZRCN)

Technology Overvalued low weak

$7.0

Updated: 2026-06-02

TradeApes Score

Financial Strength

30 Weak

Operating Trend

20 Stressed

Relative Value

40 Weak

Capital Allocation

30 Weak

Risk

70 Healthy

Est. Fair Value $3.8

DCF Upside -45.7%

Sector Rank #3395 of 8049

Key Findings

+ Low leverage — net debt/EBITDA below 1×

Unlock Full Report →

− Sharp revenue decline — sales down more than 15% year over year

Unlock Full Report →

1 free score card remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.